Sign up to save your podcasts
Or
Share Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Context and Impact of New Data
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Context and Impact of New Data
Did you know that noncovalent BTK inhibitors are potentially the answer to the development of resistance to covalent BTK inhibitors?
Credit available for this activity expires: 4/5/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/971263?src=mkm_podcast_addon_971263
View all episodes
By Medscape
4.3
2525 ratings
Did you know that noncovalent BTK inhibitors are potentially the answer to the development of resistance to covalent BTK inhibitors?
Credit available for this activity expires: 4/5/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/971263?src=mkm_podcast_addon_971263
More shows like Keeping Current CME
View all
JAMA Editors' Summary
135 Listeners
AFP: American Family Physician Podcast
694 Listeners
JAMA Clinical Reviews
496 Listeners
JACC This Week
170 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
885 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
291 Listeners
Frankly Speaking About Family Medicine
260 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
90 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
433 Listeners